Characterization of the P2Y-purinoceptor Involved in the ATP-induced Rise in Cytosolic Ca2+ Concentration in Rat Ileal Myocytes
Overview
Affiliations
1. The P2-purinoceptor subtype and the intracellular signalling mechanism(s) involved in the rise in the free cytosolic Ca2+ concentration ([Ca2+]i) induced by ATP and analogues were analyzed in myocytes isolated from the longitudinal muscle layer of rat ileum by means of molecular and physiological techniques. 2. The P2-purinoceptor expressed by ileal smooth muscle cells shared 100% amino acid identity with the rat P2Y1-receptor. 3. Short applications of the purinoceptor agonists induced a transient rise in [Ca2+]i in an all-or-nothing manner. The rank order of potency of the analogues of ATP and ADP, determined by measuring the percentage of responding cells was 2-methylthioATP = 2-chloro-ATP > ADP > ATP, with concentrations giving [Ca2+]i response in 50% of cells ranging between 3 nM and 0.6 microM. The concentration-response curves to ADP and ATP were shifted to the right by 10 microM pyridoxal phosphate-6-azophenyl-2',4'-disulphonic acid (PPADS). 4. Although the rise in [Ca2+]i induced by stimulation of the ileal P2v-purinoceptor was inhibited by heparin (5 mg ml-1), we were not able to detect stimulation of phospholipase C under conditions (37 degrees C) where muscarinic cholinoceptor activation markedly increased inositol phosphate (InsP) accumulation. However, the carbachol (CCh)-induced increase in InsP accumulation was suppressed when the agonist was applied at 20 degrees C while a CCh-induced [Ca2+]i rise similar to that obtained in response to the P2-purinoceptor agonist was still observed. 5. Our results indicate that the rat ileal myocytes express a PPADS-sensitive P2-purinoceptor similar to the P2Y1-receptor subtype. Although there is no detectable increase in InsP production, stimulation of these receptors leads to a rise in [Ca2+]i by activation of the inositol 1,4,5-trisphosphate receptor-channel of the intracellular Ca2+ store, indicating that they couple to phospholipase C.
Rodriguez-Tapia E, Naidoo V, DeVries M, Perez-Medina A, Galligan J Exp Physiol. 2016; 102(3):299-313.
PMID: 28008669 PMC: 5332280. DOI: 10.1113/EP086027.
Mader F, Krause L, Tokay T, Hakenberg O, Kohling R, Kirschstein T Acta Pharmacol Sin. 2016; 37(5):617-28.
PMID: 27018177 PMC: 4857539. DOI: 10.1038/aps.2015.137.
Jimenez M, Clave P, Accarino A, Gallego D Br J Pharmacol. 2014; 171(19):4360-75.
PMID: 24910216 PMC: 4209144. DOI: 10.1111/bph.12802.
Purinergic signalling in the gastrointestinal tract and related organs in health and disease.
Burnstock G Purinergic Signal. 2013; 10(1):3-50.
PMID: 24307520 PMC: 3944042. DOI: 10.1007/s11302-013-9397-9.
Limtipsuntorn U, Haga Y, Kondo H, Hirono I, Satoh S Mar Biotechnol (NY). 2013; 16(1):88-102.
PMID: 24052493 DOI: 10.1007/s10126-013-9535-y.